Dana Brewington
Family Medicine · Lenexa, KSNPI 1831301126
Payments from drug & device makers
Across 345 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$660
- AstraZeneca$464
- Lilly USA, LLC$462
- Pfizer$391
- Amgen$377
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,30899%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,432 |
| Novo Nordisk | 58 | $660 |
| AstraZeneca(2 entities) | 24 | $464 |
| Lilly USA, LLC | 28 | $462 |
| Pfizer | 32 | $391 |
| Amgen | 26 | $377 |
| Merck | 13 | $191 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $177 |
| Supernus Pharmaceuticals, Inc. | 7 | $118 |
| Dexcom, Inc. | 5 | $117 |
| Abbott | 6 | $109 |
| Astellas Pharma US Inc | 5 | $90 |
| Boehringer Ingelheim | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 5 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| GSK | 4 | $51 |
| Avanir Pharmaceuticals, Inc. | 3 | $49 |
| Vertex | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Johnson & Johnson | 3 | $37 |
| Bayer | 2 | $35 |
| Eisai Inc. | 2 | $35 |
| Upsher-smith Laboratories LLC | 1 | $33 |
| Exact Sciences | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $29 |
| Bioventus LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $19 |
| Organon | 1 | $17 |
| Halozyme Inc | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Dermira, Inc. | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$117
How this compares
$5,367 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $67,595 |
| JanuviaSitagliptin Phosphate | 11 | $12,328 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $9,134 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 19 | $3,125 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,588 |
| Rosuvastatin Calcium | 142 | $1,366 |
| Ondansetron OdtOndansetron | 23 | $1,000 |
| Atorvastatin Calcium | 91 | $983 |
| Duloxetine Hcl | 50 | $948 |
| Gabapentin | 52 | $758 |
| Propranolol Hcl ErPropranolol Hcl | 20 | $602 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $488 |
| Losartan Potassium | 61 | $460 |
| Levothyroxine Sodium | 60 | $453 |
| Omeprazole | 37 | $450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $660 | $67,59550 claims |
| MerckJanuvia | $191 | $12,32811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Lenexa
- Daniel DickersonLenexa$13.6M
- Casey JohnsonLenexa$499K
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.